
Grapheal raises €1.9 million to develop biosensors and fast digital COVID tests
Graphene Flagship Associate Member Grapheal receives investment for clinical studies to validate their technologies and accelerate time-to-market.
Graphene Flagship Associate Member Grapheal receives investment for clinical studies to validate their technologies and accelerate time-to-market.